Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-13

FDA Approved: CORLANOR — Supplemental Application (Amgen Inc)

View source ↗

Summary

FDA approved Amgen's supplemental application for CORLANOR (ivabradine), updating the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corlanor (ivabradine)

Snippet

SUPPL AP for CORLANOR (IVABRADINE)